Valeant (VRX) to Syndicate $500M of Incremental Term Loans
Tweet
Share
E-mail
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) announced plans to syndicate $500 million of incremental term loans under its existing senior secured credit facilities to fund repayment of amounts outstanding under its existing $275 million revolving facility and for general corporate purposes, including acquisitions.
The incremental term loans will mature in 2019 and are expected to have terms that are similar to the Company's existing $600 million Term Loan B facility, with certain modifications. The incremental term loans are expected to close in June 2012, subject to market and other customary conditions.
The incremental term loans will mature in 2019 and are expected to have terms that are similar to the Company's existing $600 million Term Loan B facility, with certain modifications. The incremental term loans are expected to close in June 2012, subject to market and other customary conditions.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boeing names Ryan Shedd as new SVP and controller
- Denarius Metals acquires 15% stake in Copper Giant, Trafigura invests
- Curvature Securities terminates ATM sales pact with Planet Green
Create E-mail Alert Related Categories
Corporate NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
